UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000014498
Receipt number R000016075
Scientific Title Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1)
Date of disclosure of the study information 2014/07/07
Last modified on 2017/07/10 15:45:24

No. Disposal Last modified on Item of update
1 Insert 2014/07/07 19:43:32
2 Update 2014/07/14 15:30:23 Acronym
3 Update 2014/10/17 09:38:26 Recruitment status
Anticipated trial start date
4 Update 2017/07/10 15:45:24 Name of primary person or sponsor
Organization